All News

Stem Cells

denovoMATRIX Expands its Product Portfolio by Launching its First Stem Cell Product
2 June 2023
denovoMATRIX Expands its Product Portfolio by Launching its First Stem Cell Product
denovoMATRIX GmbH announced the expansion
BioCentriq and panCELLa in Agreement to Study Stem Cell-derived Natural Killer Cell Expansion Technology
9 May 2023
BioCentriq and panCELLa in Agreement to Study Stem Cell-derived Natural Killer Cell Expansion Technology
BioCentriq and panCELLa Collab in
First Allogeneic Stem Cell Transplant Therapy Approved by the FDA
19 April 2023
First Allogeneic Stem Cell Transplant Therapy Approved by the FDA
Cell therapy pioneer Gamida Cell
Cell Therapy to Restore Function in Heart Failure Dosed to First Patient, Novo Nordisk and Heartseed Announce
15 February 2023
Cell Therapy to Restore Function in Heart Failure Dosed to First Patient, Novo Nordisk and Heartseed Announce
Heartseed Inc (Tokyo, Japan) and
POPULAR NEWS ITEMS
Image
8 June 2023

Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer

Image
7 June 2023

Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities

Image
5 June 2023

BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies

Genome Editing Tools and Techniques for Cancer Therapies
3 January 2023
Genome Editing Tools and Techniques for Cancer Therapies
For this interview, Phacilitate’s Ryan
Avectas, CCRM and OmniaBio’s Collaboration to Accelerate the Manufacture of Edited iPSCs
30 November 2022
Avectas, CCRM and OmniaBio’s Collaboration to Accelerate the Manufacture of Edited iPSCs
Irish based cell engineering technology
FDA Gives Go-Ahead for New Gene Therapy Clinical Trial in Cystic Fibrosis
2 August 2022
FDA Gives Go-Ahead for New Gene Therapy Clinical Trial in Cystic Fibrosis
Pivotal-stage gene therapy company Krystal
First Patient Successfully Treated by Ex Vivo Lentiviral Gene Therapy for RAG1-SCID
1 August 2022
First Patient Successfully Treated by Ex Vivo Lentiviral Gene Therapy for RAG1-SCID
Mustang Bio has announced that
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer

Image

Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities

Image

BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies